FSMAX
Price
$119.11
Change
+$0.28 (+0.24%)
Updated
Aug 19 closing price
Net Assets
40.08B
TMAPX
Price
$58.61
Change
+$0.45 (+0.77%)
Updated
Aug 19 closing price
Net Assets
3.51B
Interact to see
Advertisement

FSMAX vs TMAPX

FSMAX vs TMAPX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. TMAPX commentary
Aug 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and TMAPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.1B vs. TMAPX (3.51B). FSMAX pays higher dividends than TMAPX: FSMAX (0.50) vs TMAPX (0.01). FSMAX was incepted earlier than TMAPX: FSMAX (15 years) vs TMAPX (19 years). TMAPX (1.18) is less costly to investors than FSMAX (0.04). FSMAX is a more actively managed with annual turnover of: 23.00 vs. TMAPX (12.00). FSMAX has a lower initial minimum investment than TMAPX: FSMAX (0) vs TMAPX (2500). FSMAX annual gain was more profitable for investors over the last year : 24.51 vs. TMAPX (4.54). FSMAX return over 5 years is better than : 41.46 vs. TMAPX (23.26).
FSMAXTMAPXFSMAX / TMAPX
Total Expense Ratio0.041.183%
Annual Report Gross Expense Ratio0.041.183%
Fund Existence15 years19 years-
Gain YTD18.0394.698384%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets40.1B3.51B1,144%
Annual Yield % from dividends0.500.013,812%
Returns for 1 year24.514.54540%
Returns for 3 years74.0223.83311%
Returns for 5 years41.4623.26178%
Returns for 10 years138.54120.80115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNTA1.220.05
+4.27%
Genenta Science SpA
STOK33.030.89
+2.77%
Stoke Therapeutics
FCNCO20.700.17
+0.83%
First Citizens BancShares
ENSG182.49N/A
N/A
Ensign Group (The)
CYH2.92-0.06
-2.01%
Community Health Systems